Glucagon‐like peptide‐1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials
出版年份 2019 全文链接
标题
Glucagon‐like peptide‐1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials
作者
关键词
-
出版物
DIABETES-METABOLISM RESEARCH AND REVIEWS
Volume -, Issue -, Pages e3168
出版商
Wiley
发表日期
2019-04-12
DOI
10.1002/dmrr.3168
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Differential Mortality and the Excess Rates of Hip Fracture Associated With Type 2 Diabetes: Accounting for Competing Risks in Fracture Prediction Matters
- (2018) Cristian Tebé et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effects of diabetes therapy on bone: A clinical perspective
- (2018) Karim G. Kheniser et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- The Impact of Type 2 Diabetes on Bone Fracture Healing
- (2018) Carlos Marin et al. Frontiers in Endocrinology
- Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
- (2018) Raffaella Gentilella et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Overweight and underweight are risk factors for vertebral fractures in patients with type 2 diabetes mellitus
- (2018) Ippei Kanazawa et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study
- (2017) D. Martinez-Laguna et al. OSTEOPOROSIS INTERNATIONAL
- Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study
- (2017) Y. C. Hung et al. OSTEOPOROSIS INTERNATIONAL
- Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis
- (2017) Ardeshir Moayeri et al. Therapeutics and Clinical Risk Management
- The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms
- (2017) Chenhe Zhao et al. Frontiers in Endocrinology
- Glycemic control and fracture risk in elderly patients with diabetes
- (2016) Baqiyyah N. Conway et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Mechanisms of diabetes mellitus-induced bone fragility
- (2016) Nicola Napoli et al. Nature Reviews Endocrinology
- Once-daily liraglutide (1.2 mg) compared with twice-daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta-analysis
- (2016) Stephen M. Twigg et al. Journal of Diabetes
- Activation of GLP-1 Receptor Promotes Bone Marrow Stromal Cell Osteogenic Differentiation through β-Catenin
- (2016) Jingru Meng et al. Stem Cell Reports
- Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis
- (2015) Johanna H. M. Driessen et al. CALCIFIED TISSUE INTERNATIONAL
- GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women
- (2015) Eva W. Iepsen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone Cells and Bone Turnover in Diabetes Mellitus
- (2015) Mishaela R. Rubin Current Osteoporosis Reports
- GLP-1: benefits beyond pancreas
- (2014) G. Muscogiuri et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Glucagon-Like Peptide-1: Glucose Homeostasis and Beyond
- (2013) Young Min Cho et al. Annual Review of Physiology
- Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)
- (2013) J. Rosenstock et al. DIABETES CARE
- Complications of Diabetes Therapy
- (2013) Sarah D. Corathers et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats
- (2013) Xue Ma et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Complications du diabète de type 2
- (2013) Jean-Louis Schlienger PRESSE MEDICALE
- Bone: Incretin Hormones Perceiver or Receiver?
- (2012) Ilaria Dicembrini et al. Experimental Diabetes Research
- Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
- (2012) John B Buse et al. LANCET
- Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation
- (2010) Lotte Bjerre Knudsen et al. ENDOCRINOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started